The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Landscape of GATA3 mutations identified from circulating tumor DNA clinical testing and their impact on disease outcomes in estrogen receptor-positive (ER+) metastatic breast cancers treated with endocrine therapies.
 
Marko Velimirovic
Stock and Other Ownership Interests - Abbvie; Amgen
 
Lorenzo Gerratana
Consulting or Advisory Role - Lilly; Novartis
Travel, Accommodations, Expenses - Menarini Silicon Biosystems
 
Andrew A. Davis
No Relationships to Disclose
 
Charles Sichao Dai
No Relationships to Disclose
 
Ju Cheng
No Relationships to Disclose
 
A. John Iafrate
Stock and Other Ownership Interests - Archer
Consulting or Advisory Role - Chugai Pharma; Debiopharm Group; Repare Therapeutics; Roche
Research Funding - Sanofi; Sanofi
Patents, Royalties, Other Intellectual Property - ArcherDx exclusive license to AMP technology
 
Bruce Allan Chabner
Stock and Other Ownership Interests - Alnylam; Biomarin; Blueprint Medicines; Blueprint Medicines; Celgene; Constellation Pharmaceuticals; Epizyme; GlaxoSmithKline; Loxo; PharmaMar; Seagen; SpringWorks Therapeutics
Honoraria - Bristol Myers Squibb; Bristol Myers Squibb
Consulting or Advisory Role - Chugai Pharma; cyteir; EMD Serono; PharmaMar
Expert Testimony - Lilly
Travel, Accommodations, Expenses - PharmaMar
 
Massimo Cristofanilli
Honoraria - Foundation Medicine; Pfizer
Consulting or Advisory Role - CytoDyn; Foundation Medicine; Lilly; Menarini; Novartis
Research Funding - Angle; Lilly; Merck
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Daiichi Sankyo/Astra Zeneca; Foundation Medicine; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Philips Healthcare; Puma Biotechnology; Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)